Skip to content
Finasteride Info

Finasteride Info

Emerging evidence & commentary on risks of finasteride as a treatment for hair loss

  • Home
  • Drug information
    • Overview
    • Drug labels
    • The making of finasteride
    • Historical timeline
  • Weighing risks
    • Lasting dysfunctions
    • Firsthand reports
    • Weighing the risks of taking finasteride
    • Adverse event data
    • Doctors expressing concerns
  • Research
    • Research overview
    • 2020–present
    • By system & function
    • – Lasting dysfunctions
    • – Effects on fertility
    • Special topics
    • Clinical trials
    • Related research
    • Grey literature
    • Guide for researchers
    • History of research
  • Resources
    • Resources – main
    • Physicians expressing concerns
    • Historical timeline
    • News & media coverage
    • Regulatory document library
    • Regulatory communications
    • Legal matters
    • The Merck files
    • Posts archive
    • About this site

Etiopathology

A proposed explanation of lasting dysfunctions after use of finasteride or dutasteride

November 17, 2022February 24, 2022 by Montaigne

Men who previously took finasteride and dutasteride have reported sexual dysfunction, anxiety, depression, cognitive problems and other dysfunctions which have continued long after stopping the drug. This paper proposes an explanation for how these dysfunctions may develop.

Categories Research Tags Etiopathology, PD-5ARI, Research

Many websites tout the benefits of finasteride for treating hair loss, while downplaying the risks. This site is different: it puts risks in the foreground, accompanied by supporting evidence. Learn more

  • Considering taking finasteride or dutasteride for hair loss? See Weighing the risks

Navigator

  • Adverse event data
  • Drug information
  • Drug origins
  • Firsthand reports
  • Legal actions
  • Media coverage
  • Post-drug disorder
  • Regulatory activity
  • Research
  • Timeline
  • Weighing the risks

Categories

  • Adverse event reports (18)
  • Doctor views (8)
  • FDA (6)
  • Firsthand experiences (14)
  • History & context (7)
  • Merck (14)
  • News (5)
  • Research (18)
Tweets by FinasterideInfo
  • Home
  • Drug information
  • Research
  • Posts archive
  • About & contact
  • Medical Disclaimer

Recent Posts

  • Disinformation is a weapon in the war over finasteride safety
  • How Merck buried finasteride’s full impact on chemical signaling
  • A rundown of new bibliographies & research guides
  • 2022 – year in review
  • Rules of engagement: how sensitive concerns are hidden from drug trials

Post categories

  • Adverse event reports (18)
  • Doctor views (8)
  • FDA (6)
  • Firsthand experiences (14)
  • History & context (7)
  • Merck (14)
  • News (5)
  • Research (18)

© 2020–2023 Finasteride Info  •  Privacy Policy
This website is not a substitute for professional medical advice, diagnosis or treatment. See Medical Disclaimer